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doi:10.1016/j.kjms.2011.10.026Abstract This study investigated whether KMUP-1, a xanthine-based derivative, inhibits L-
type Ca2þ currents (ICa,L) in rat basilar artery smooth muscle cells (RBASMCs). We used whole
cell patch-clamp recording to monitor Ba2þ currents (IBa) through L-type Ca
2þ channels
(LTCCs). Under voltageeclamp conditions, holding at e40 mV, KMUP-1 (1, 3, 10 mM) inhibited
IBa in a concentration-dependent manner and its IC50 value was 2.27 0.45 mM. A high concen-
tration of KMUP-1 (10 mM) showed without modifying the IBa currentevoltage relationship. On
the other hand, the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA,
1 mM) increase IBa was inhibited by KMUP-1. Pretreatment with the PKC inhibitor chelerythrine
(5 mM) intensified KMUP-1-inhibited IBa. However, the Rho kinase inhibitor Y-27632 (30 mM)
failed to affect the IBa inhibition by KMUP-1. In light of these results, we suggest that KMUP-
1 inhibition of LTCCs in concentration- and voltage-dependent manners in RBASMCs may be
due, at least in part, to its modulation of the PKC pathway.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.of Pharmacology, School of
iung Medical University, 100
Taiwan.
tw (B.-N. Wu).
vier Taiwan LLC. All rights reservIntroduction
KMUP-1 (7-{2-[4-(2-chlorobenzene)piperazinyl]ethyl}-1,3-
dimethylxanthine) has been demonstrated to raise cyclic
nucleotides, inhibit phosphodiesterases and stimulate Kþ
channels resulting in relaxations in aortic [1], corporeal
cavernosa [2], and tracheal smooth muscles [3]. Its smoothed.
KMUP-1-inhibited Ca2þ channels 539muscles relaxations could be mediated via two major
pathways, either via activation of Kþ channels that are
independent of cellular cyclic nucleotides, or through
increases in both cyclic adenosine monophosphate (cAMP)
and cyclic guanosine monophosphate (cGMP), followed by
stimulation of protein kinase A (PKA) and G (PKG) cascades.
Elevated PKA and PKG appear to activate Kþ channels, thus
resulting in the lowering of cellular Ca2þ levels [3].
Furthermore, we have provided the evidence that KMUP-1
activates large-conductance Ca2þ-activated Kþ (BKCa)
currents in basilar artery myocytes [4]. The findings sug-
gested that KMUP-1 could reduce the activity of Ca2þ chan-
nels by two routes; directly, by its Ca2þ channel blocking
action, and indirectly by activating BKCa channels producing
hyperpolarization, thus decreasing the open probability of
Ca2þ channels through their voltage-dependence. However,
the direct ionic mechanism by which KMUP-1 inhibits basilar
artery Ca2þ currents remains undetermined. Therefore, this
study aimed to look into the effects of KMUP-1 on voltage-
dependent Ba2þ currents (IBa,) through L-type Ca
2þ chan-
nels (LTCCs), targeting the applicability of KMUP-1 for
cerebral artery dilatation.
LTCCs are activated by membrane depolarization, and
their function is subject to modulation by signaling mole-
cules such as protein kinase C (PKC) [5,6] or RhoA/Rho
kinase [7,8]. These channels play an indispensable role in
many signaling pathways requiring Ca2þ influx for activation
of intracellular Ca2þ-dependent molecules [9]. LTCCs and
intracellular Ca2þ [(Ca2þ)i] have a critical role in regulating
many cellular functions in vascular smooth muscle cells
(VSMCs), including contraction and relaxation. This may be
of importance because alterations in the expression of
LTCCs and [Ca2þ]i levels have been linked to several path-
ologic processes that involve VSMCs, including hyperten-
sion, coronary vasospasm, and atherosclerosis [7].
The main objective of this study was to address the
mechanism by which KMUP-1 could modulate LTCCs in rat
basilar artery smooth muscles (RBASMCs). Accordingly,
whole cell patch-clamp electrophysiology was used to study
whether KMUP-1 inhibited the LTCCs activity through PKC-
dependent and/or -independent signaling pathways.
Methods
Animal procedures and tissue preparations
All procedures and protocols were approved by the Animal
Care and Use Committee at the Kaohsiung Medical Univer-
sity. Briefly, female Sprague Dawley rats (10e12 weeks of
age) were euthanized by carbon dioxide asphyxiation. The
brain was carefully removed and placed in cold phosphate-
buffered saline containing (in mM): 138 NaCl, 3 KCl, 10
Na2HPO4, 2 NaH2PO4, 5 glucose, 0.1 CaCl2, and 0.1 MgSO4
(pH 7.4). The basilar arteries were dissected free of the
surrounding tissue and cut into 2-mm segments.
Preparation of isolated arterial smooth muscle cells
RBASMCs from rat basilar arteries were enzymatically iso-
lated as previously described [4,10]. In brief, arterial
segments were placed in warm (37C) cell isolation mediumcontaining (in mM): 60 NaCl, 80 Na-glutamate, 5 KCl,
2 MgCl2, 10 N-(2-Hydroxyethyl)piperazine-N
0-(2-ethane-
sulfonic acid) (HEPES), and 10 glucose with 1 mg/ml albumin
(pH 7.2) for 10 minutes. After this equilibration step, arterial
segments were initially incubated (37C) in 1 mg/ml papain
and 3 mg/ml dithioerythritol for 20 minutes. This was fol-
lowed by a second incubation (37C) in isolation medium
containing 100 mM Ca2þ, 0.7 mg/ml type F collagenase, and
0.4 mg/ml type H collagenase for 10 minutes. After enzyme
treatment, the tissue was washed three times in ice-cold
isolation medium and triturated with a fire-polished
pipette to release the myocytes. RBASMCs were stored in
ice-cold isolation medium for use on the same day.
Patch-clamp electrophysiology
To measure the IBa through LTCCs, whole cell patch-clamp
recording was performed [10]. In brief, RBASMCs were put
in a recording dish and perfused with a bath solution con-
taining (in mM): 120 NaCl, 10 tetraethylammonium (TEA)-Cl,
5 BaCl2, 0.5 MgCl2, 5.5 glucose, 10 HEPES, 5 CsCl, and 0.001
tetrodotoxin (pH 7.4, CsOH). To minimize outward Kþ
currents, Csþ rather than Kþwas used in the pipette solution.
A recording electrode was pulled from borosilicate glass
(resistance: 4e7 megaohm), the pipette was coated with
sticky wax close to the tip to reduce capacitance, and it was
backfilled with pipette solution containing (in mM): 140 CsCl,
5 ethylene glycol-bis(2-aminoethylether)-N,N,N0,N0-tetra-
acetic acid (EGTA), 1 MgCl2, 5 Na2ATP, 1 guanosine triphos-
phate, 5 HEPES, and 5 CsOH (pH 7.2, CsOH). It was then gently
lowered onto a smooth muscle cell. Negative pressure was
briefly applied to rupture the membrane and a gigaohm seal
was obtained. Cells were subsequently voltage clamped
(e40 mV). Membrane currents were recorded on an Axopatch
700 A amplifier (Axon Instruments, Union City, CA), filtered at
1 kHz using a low-pass Bessel filter, digitized at 5 kHz, and
stored on a computer for subsequent analysis with Clampfit
9.0 (Axon Instruments, Union City, CA). A 1-M NaCl-agar salt
bridge between the bath and the AgeAgCl reference elec-
trode was used to minimize offset potentials. All electro-
physiologic recordings were performed at room temperature.
Experimental procedures
To evoke whole-cell IBa (or ICa), RBASMCs were clamped at
e40 mV with step depolarizations (200 milliseconds) from
e40 to 50 mV. Voltage clamped cells were equilibrated for
15 minutes prior to experimentation. Following equilibra-
tion, inward IBa was monitored in the presence and absence
of KMUP-1 (1 mM). To ascertain whether PKC or Rho kinase
signaling were involved in the KMUP-1-mediated IBa inhibi-
tion, RBASMCs were preincubated for 15 minutes with
phorbol 12-myristate 13-acetate (PMA, 1 mM), chelerythrine
(5 mM), or Y-27632 (30 mM) prior to the addition of KMUP-1.
PMA, chelerythrine, or Y-27632 was continuously super-
fused in the bath solution.
Data analysis and statistics
Data are expressed as means SE and n indicates the
number of cells. Repeated measures of analyses of variance
Figure 1. External Ca2þ solution was substituted by BaCl2 (Ba
2þ). (A) Replacement of 1.8 mM Ca2þ with 5 mM Ba2þ resulted in
increases of the inward current evoked by a step from e40 to 10 mV; (B) time course of Ba2þ current (IBa) under control conditions.
The peak IBa amplitude was plotted against time. About 12 minutes later, the current amplitude reached the steady state (nZ 6).
540 J.-Y. Chen et al.compared values at a given voltage. When appropriate,
a Tukey-Kramer pairwise comparison was used for post hoc
analysis. The p values 0.05 were considered statistically
significant.Results
Steady-state of inward IBa
Using a whole-cell patch clamp and pipette solution con-
taining Csþ in this experiment, RBASMC was clamped at
e40 mV and continuously superfused with an isotonic
physiologic solution containing 1.8 mM Ca2þ or 5 mM Ba2þ.
RBASMC was depolarized from e40 to 10 mV to produce an
inward IBa through LTCCs. Rapid inactivation of LTCCs
observed in perfusing 1.8 mM Ca2þ solution while replaced
with 5 mM Ba2þ retarded the inactivation and enhanced this
inward current. The IBa was constantly observed 30 minutes
after cell disruption, with the peak, steady-state level
occurring w12 minutes (Fig. 1).Figure 2. Effects of KMUP-1 (1, 3, 10 mM) on inward IBa in RBASMC
10 mV from a holding potential of e40 mV, before and after per
absence and presence of different concentrations of KMUP-1 (nZInhibition of inward IBa by KMUP-1
Whole-cell patch clamp recording was used to measure the
effect of KMUP-1 (1, 3, 10 mM) on the regulation of LTCCs
(Fig. 2). At the holding potential of e40 mV, KMUP-1 exhibi-
ted a concentration-dependent inhibition of inward IBa and
its IC50 value was 2.27 0.45 mM. KMUP-1 (10 mM) inhibited
IBa in w25% of control cells, but the dihydropyridine-
sensitive LTCC blocker nifedipine (1 mM) nearly abolished
the current (data not shown). Additionally, depolarizing step
pulses (10 mV increments from e40 to 50 mV for 200 milli-
seconds) were applied from a holding potential of e40 mV.
Fig. 3 shows the current-voltage (IeV) relationships of 10 mM
KMUP-1-mediated IBa obtained ate40 mV. We observed that
at potentials more positive than e30 mV, an inward IBa was
evoked; this reached apeak and then gradually decayed. The
amplitude of this current was voltage-dependent; the
maximum peak amplitude was observed at approximately
10 mV and then was reduced at more positive potentials.
After 20 minutes of drug washout, the recovery of peak
current of KMUP-1-mediated IBa wasw85%.s. (A) Representative recordings of IBa evoked by a test pulse to
fusion with KMUP-1. (B) Bar graph showing the effects in the
6). * Denotes significant difference from control.
Figure 3. The IeV relationships of KMUP-1 (10 mM) on inward IBa in RBASMCs. (A) Voltage protocol was designed to measure the
IBa. Representative recordings of IBa evoked by a series of depolarizing pulse (200 ms, range from e40 to 50 mV) from a holding
potential of e40 mV in the absence and presence of KMUP-1; (B) average IeV relationship of the peak IBa in the absence (B) and
presence (C) of KMUP-1 (nZ 6). * Denotes significant difference from control.
KMUP-1-inhibited Ca2þ channels 541PKC and/or Rho kinase involved the KMUP-1-
mediated IBa inhibition
A perfused PKC activator PMA (1 mM) enhanced the inward
IBa in RBASMCs. KMUP-1 (10 mM) fully eliminated the
PMA-enhanced inward current and further reduced the
basal IBa (Fig. 4). Perfusate with a PKC inhibitor cheler-
ythrine (5 mM, Fig. 5) or a Rho kinase inhibitor Y-27632
(30 mM, Figure 6) inhibited the IBa in RBASMCs. Cheler-
ythrine reinforced KMUP-1 (1 mM)-mediated IBa inhibition
(Fig. 5), but Y-27632 did not affect KMUP-1-mediated
current inhibition (Fig. 6). From these results, we suggest
that KMUP-1-mediated IBa inhibition could be due, at least
in part, to its modulation of the PKC pathway.Figure 4. Effects of KMUP-1 (10 mM) on PMA (1 mM)-induced activa
IBa evoked by a test pulse to 10 mV from a holding potential of e40
bar graph showing the relative IBa under control conditions and in th
significant difference from control.Discussion
The pivotal findings of this study are that KMUP-1 inhibits
the LTCCs in RBASMCs in a concentration-dependent
manner. We observed that the PKC activator, PMA-
induced inward IBa increment is reversed by adding KMUP-
1 in perfusate. The PKC inhibitor chelerythrine augments
KMUP-1-mediated IBa inhibition, but it was not found in Rho
kinase inhibitor Y-27632. Taken together, we suggest that
KMUP-1-mediated LTCCs inhibition results at least partly
from modulation of the PKC pathway.
Voltage-dependent LTCCs play a crucial role in the
regulation of vascular tone by membrane potential:
hyperpolarization closes these channels and leads totion of inward IBa in RBASMCs. (A) Representative recordings of
mV before and after perfusion with PMA or PMAþ KMUP-1; (B)
e presence of PMA, KMUP-1 or PMAþ KMUP-1 (nZ 6). * Denotes
Figure 5. Effects of the PKC inhibitor chelerythrine (5 mM) on KMUP-1 (10 mM)-inhibited inward IBa in RBASMCs. (A) Represen-
tative recordings of IBa evoked by a test pulse to 10 mV from a holding potential of e40 mV before and after perfusion with
chelerythrine or chelerythrineþ KMUP-1; (B) bar graph showing the relative IBa under control conditions and in the presence of
chelerythrine, KMUP-1, or chelerythrineþ KMUP-1 (nZ 6). * Denotes significant difference from control. ** Denotes significant
difference between the two groups.
542 J.-Y. Chen et al.vasodilation, whereas depolarization opens them, resulting
in vasoconstriction [11]. Dihydropyridine-sensitive LTCCs
seem to be dominant in most VSMCs. In the microcircula-
tion, LTCCs appear to play a particularly important role in
myogenic reactivity and vasomotion [12]. Voltage-
dependent LTCCs are modulated by several signaling
systems. They appear to be activated by vasoconstrictors
that activate the PKC pathway [12]. In this study, KMUP-1-
mediated IBa inhibition through LTCCs is attributed to its
voltage-dependence in RBASMCs, also found in
dihydropyridine-sensitive LTCC blocker nifedipine [13]. In
addition, KMUP-1-sensitive IBa is not mediated by a Na
þ or
Kþ channel because the extracellular and/or intracellular
solutions used contain the voltage-sensitive Naþ channel
blocker tetrodotoxin and the Kþ channel blockers Csþ andFigure 6. Effects of the Rho kinase inhibitor Y-27632 (30 mM) o
sentative recordings of IBa evoked by a test pulse to 10 mV from a
27632 or Y-27632þ KMUP-1; (B) bar graph showing the relative IBa un
or Y-27632þ KMUP-1 (nZ 6). * Denotes significant difference fro
groups.TEA. From the findings, we suggest that KMUP-1-mediated
voltage-dependent LTCCs inhibition would modulate the
cerebral artery tone and circulation.
It is widely accepted that the activation of PKC promotes
the opening of voltage-dependent LTCCs [5,6,12]. In this
study, we further confirmed that the PKC activator PMA
enhanced the inward IBa through LTCCs in RBASMCs [13].
Notably, KMUP-1 not only abolished the PMA-increased
inward current, but it also attenuated the basal IBa. The
PKC inhibitor chelerythrinedbut not the Rho kinase inhib-
itor Y-27632denhanced KMUP-1-mediated IBa inhibition.
These results strongly indicated that KMUP-1-mediated IBa
inhibition through LTCCs could be attributed to PKCdbut
not Rho kinasedmodulation. In addition to PKC modulation
by KMUP-1, however, we cannot exclude the possibility thatn KMUP-1 (10 mM)-inhibited inward IBa in RBASMCs. (A) Repre-
holding potential of e40 mV before and after perfusion with Y-
der control conditions and in the presence of Y-27632, KMUP-1,
m control. ** Denotes significant difference between the two
KMUP-1-inhibited Ca2þ channels 543PKC-independent and other unidentified mechanisms, e.g.,
store-operated Ca2þ channels, might be also involved.
In conclusion, this study provides the direct evidence
that a xanthines derivative KMUP-1 inhibits Ca2þ/Ba2þ entry
via voltage-dependent LTCCs in RBASMCs, which could be
attributed to its modulation of the PKC pathway. From one
of our published reports [4], we also suggest that KMUP-1
could have an indirect action on Ca2þ entry due to its
activation of BKCa channels producing hyperpolarization,
thus decreasing the open probability of Ca2þ channels. In
light of our results, we suggest that KMUP-1’s Ca2þ entry
inhibitory mechanisms could be primarily responsible for its
vasorelaxant effect on RBASMCs during PKC inhibition.
Thus, we suggest that the inhibitory action of KMUP-1 on
voltage-dependent LTCCs may be of pharmacologic advan-
tage to attenuate subarachnoid hemorrhage-induced cere-
bral vasospasm.
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